“Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s397. Accessed April 13, 2025. https://skin.dermsquared.com/skin/article/view/2589.